After independence, Mozambique had very few surgeons for a large, mostly rural population. Women in rural districts who needed emergency caesarean sections faced long, dangerous journeys or no surgery at all. So the country trained a cadre of mid-level clinicians, técnicos de cirurgia, to perform major emergency surgery, including caesareans, at district hospitals.
The results have been studied repeatedly. A comparative study of caesarean deliveries found no meaningful differences in major outcomes between these assistant medical officers and obstetricians, with only a slightly higher rate of superficial wound separation in the técnicos’ patients. An economic evaluation by Margaret Kruk and colleagues, published in BJOG in 2007, estimated the 30-year cost per major obstetric operation at US$38.9 for técnicos de cirurgia against US$144.1 for surgeons and obstetrician-gynaecologists. Even after doubling the técnicos’ salaries in the model, they remained far cheaper.
That is the core of the case for task-shifting. And yet in almost every country, proposals to expand scope of practice trigger the same fierce resistance. The disagreement is usually framed around safety. Often, it is really about something else.
What the evidence supports
Task-shifting, or task-sharing, means moving specific tasks from highly trained health workers to those with shorter training, where it can be done safely. The WHO issued global recommendations on task-shifting for HIV in 2008, when antiretroviral treatment needed to reach millions of people in countries with very few doctors. Nurses initiating and managing HIV treatment, lay workers supporting adherence, and community workers delivering prevention became routine.
Ethiopia built its Health Extension Program on a similar logic, deploying around 40,000 health extension workers, typically two per kebele of around 1,000 households, to deliver prevention, immunisation and basic curative services close to home.
The pattern across these experiences is consistent. When tasks are well defined, workers are properly trained, supervision is real and referral routes work, outcomes for the delegated tasks can be comparable to those achieved by more highly trained staff.
The arithmetic, and where it leaks
The Kruk figures are worth sitting with. A gap of roughly US$105 per major operation sounds modest until you multiply it. A health system performing 10,000 emergency obstetric operations a year through mid-level surgical clinicians rather than specialists would, on those estimates, free something over a million dollars a year. For a ministry of health in a low-income country, that is a district hospital’s worth of drugs, or the salaries of a supervision team that covers several provinces.
But the saving is not automatic, and this is where most business cases for task-shifting quietly go wrong. The cheaper worker is cheaper mainly because training is shorter and salaries are lower. The costs that make the arrangement safe, such as supervisors’ time, refresher training, audit of outcomes and a referral ambulance that actually comes, do not show up in the per-procedure comparison. When a finance ministry banks the full difference and funds none of the scaffolding, it has not bought task-shifting. It has bought a lower wage bill and a delayed risk.
A sensible rule of thumb is that some meaningful share of the saving should be ring-fenced for the system that protects it. The exact share is a local judgement. The principle is not: the scaffolding is part of the price, not an optional extra.
The conditions are the intervention
Here is the part both advocates and opponents often skip. The safety of task-shifting does not come from the worker’s title. It comes from the system around them. Mozambique’s técnicos were not simply told to operate. They were trained in a structured programme and worked within a defined scope.
Task-shifting done badly looks different: a nurse left alone to manage conditions beyond her training because there is no doctor, no protocol and no one to call. That is not task-shifting. It is abandonment with a new job title. And its failures are often used to argue against the well-designed version.
For any expansion of scope, the key questions are practical:
- Is the task clearly defined? Delegating “primary care” is vague. Delegating hypertension management according to a protocol is measurable.
- Is the training competency-based, with assessment, not just attendance?
- Is there real supervision and a clear route to escalate cases?
- Does the referral system work, so complex cases reach someone who can manage them?
- Is performance monitored, so problems are detected and corrected?
- Are workers paid and recognised for the expanded role, so they stay in it?
There is also a quieter benefit that rarely appears in cost-effectiveness studies. A mid-level cadre recruited from and trained for district settings is built to work where the specialists are not, rather than to compete for posts in teaching hospitals. Access is not only about whether a task can be done safely. It is about whether anyone qualified to do it is present at 2 a.m. in the district hospital when it is needed.
A worked example: blood pressure in a rural district
Consider something far more common than a caesarean. A rural district has one doctor and several thousand adults with high blood pressure, most of them undiagnosed or untreated. If every diagnosis and every medication change must pass through that doctor, the arithmetic is hopeless. Even at ten minutes a visit and four visits a year, a few thousand patients would consume far more than one clinician’s working year before anyone with a fever, a fracture or a complicated pregnancy is seen.
Now split the task. Community health workers screen and measure. Nurses start and adjust treatment according to a simple, fixed-dose protocol with clear thresholds. The doctor sees the patients the protocol flags: those whose pressure will not come down, who have kidney disease, who are pregnant. Suddenly the doctor’s time goes to the cases that need it, and the routine work gets done at all.
What makes this safe is not the nurse’s courage. It is the protocol, a reliable drug supply, a register that shows who has missed follow-up, and a doctor who reviews a sample of charts each month. Remove any of those and the model degrades. Remove all of them and you are back to the abandonment described above.
The debate in wealthier countries
In high-income countries, the same argument plays out in regulation. In the United States, the American Association of Nurse Practitioners counts 27 states, Washington, D.C. and two territories as granting nurse practitioners full practice authority, meaning they can evaluate, diagnose, treat and prescribe under the authority of the state nursing board without a required physician agreement. Other states restrict practice to varying degrees. Similar debates surround pharmacist prescribing, physician associates and advanced paramedics elsewhere.
Professional associations on both sides cite safety and quality. But it is worth noticing the incentives. Scope of practice determines who can bill for what, who controls clinical territory and whose professional identity rests on exclusive tasks. That does not make safety concerns illegitimate. It does mean they should be judged against evidence, not accepted because of who raises them.
The strongest objection, taken seriously
The best argument against broad scope expansion is not about technical skill in a defined procedure. It is about the undifferentiated patient. A protocol works when you already know what the problem is. The hard part of medicine is often working out what the problem is: the headache that is a bleed, the tiredness that is a leukaemia, the chest pain that is not muscular. Longer training buys exposure to rare presentations, and rarity is exactly what short training cannot cover.
That objection partly holds. It is a good reason to shift defined tasks rather than whole roles, and to be more cautious about independent first-contact care for undifferentiated complaints than about managing a known condition to protocol. It is also a reason to build diagnostic safety nets, such as easy escalation and review of missed diagnoses, into any expanded role.
Where the objection fails is when it is used to block the defined tasks too. The Mozambican caesarean is not an undifferentiated problem. Neither is titrating an antihypertensive or restarting antiretroviral therapy. Treating every expansion as if it were independent general practice is a rhetorical move, and a convenient one for anyone whose income depends on the task staying where it is.
There are second-order effects to watch as well. When a cadre takes on more, the professionals above it can lose routine volume and, with it, some skills and income. Trainee doctors may get fewer straightforward cases to learn on. And a new cadre, once established, often begins lobbying for its own protected territory. None of this argues against task-shifting. It argues for designing the career structure deliberately rather than leaving it to turf wars.
The uncomfortable trade-off
There is a genuine risk on the other side as well. Task-shifting can be used as a cheap substitute for investing in the health workforce, loading ever more responsibility onto lower-paid cadres, often women, without the training, supervision, pay or career progression the role demands. That model burns people out and eventually fails patients.
The honest position is neither “protect the profession” nor “delegate everything.” It is: delegate specific tasks, and invest in the system that makes delegation safe.
What this asks of each player
For ministries of health, the practical step is to write scope by task, not by title, and to publish the outcome data that justifies each change. A regulation that says what a nurse may do for which condition, under which protocol and with what escalation, is easier to defend and easier to audit than one that argues about professional labels.
For hospital and district managers, the test is whether supervision appears in the budget and the rota. If no one’s job description includes reviewing the expanded cadre’s work, the supervision does not exist, whatever the policy says.
For funders, the temptation is to pay for training courses because they are countable and photogenic. The better investment is usually the dull middle layer: supervisors, registers, drug supply and referral transport. For professional bodies, the credible position is to argue about evidence and conditions, not about exclusivity. And for regulators in high-income countries, it is to require outcome monitoring as the price of expanded authority, which serves patients and gives the evidence debate something better than anecdote to work with.
For clinicians themselves, the most useful stance may be the least comfortable one: to become the supervisors, trainers and escalation point for the cadres taking on delegated work, rather than their opponents. A specialist who spends part of each week reviewing mid-level clinicians’ cases extends her reach far beyond the patients she can personally see. That is a different job from the one most specialists trained for, and it deserves to be recognised and paid as such.
Over the next year or two, the signals worth watching are less the headline legislative fights than the unglamorous details: whether expanded-scope roles come with funded supervision, whether outcome data is collected and published, and whether pay follows responsibility. Where those things happen, the safety argument tends to settle itself.
The takeaway
The evidence on task-shifting has been clear for years. Well-defined tasks, done by trained and supervised workers within working systems, can be delivered safely and at far lower cost. The real debate is rarely about whether it can work. It is about who controls the work, who gets paid for it and whether governments are willing to fund the supervision and support that make it safe.
Which scope-of-practice change has made the biggest difference where you work, and what made it safe? Tell us in the comments.
